Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hyperion initiates pediatric study of Ravicti for urea cycle disorders

Feb. 12, 2015

Strategic Science and Technologies begins phase I study of topical sildenafil

Feb. 12, 2015

JCR begins clinical study of biosimilar for Fabry's disease

Feb. 11, 2015

Otsuka Pharmaceutical patents citric acid cycle activators

Feb. 11, 2015

NDA filed for ibandronate sodium hydrate in Japan

Feb. 11, 2015

Boehringer Ingelheim Pharma presents new AMPK activators

Feb. 10, 2015

Sanofi targets U.S. Lyxumia submission and LixiLan filings

Feb. 9, 2015

BP-2001 reprograms intestinal cells into insulin-secreting cells in diabetes model

Feb. 9, 2015

Takeda discloses new MCHR-1 antagonists

Feb. 6, 2015

Ligand signs license agreement with Sermonix for lasofoxifene

Feb. 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...